A multi-omics approach to understand and predict therapeutic success of anti-TNF and anti-integrin agents in inflammatory bowel disease
Ontology highlight
ABSTRACT: In this study we wanted to identify baseline predictors of successful anti-TNF and vedolizumab therapy in patients with inflammatory bowel disease (based on tissue transcriptomics and CD4/CD14 transcriptomics)
INSTRUMENT(S): Illumina HiSeq 4000
ORGANISM(S): Homo sapiens
SUBMITTER: Bram Verstockt
PROVIDER: E-MTAB-7914 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA